(Q44326373)

2 December 2017

title

Clinical use of hyaluronic acid as a predictor of fibrosis change in hepatitis C. (English)

1 reference

2 December 2017

3

Shanon Heaton

1 reference

2 December 2017

Keyur Patel

1

1 reference

2 December 2017

Adrianne Lajoie

2

1 reference

2 December 2017

Stephen Pianko

4

1 reference

2 December 2017

Cynthia A Behling

5

1 reference

2 December 2017

David Bylund

6

1 reference

2 December 2017

Paul J Pockros

7

1 reference

2 December 2017

Lawrence M Blatt

8

1 reference

2 December 2017

Andrew Conrad

9

1 reference

2 December 2017

John G McHutchison

10

1 reference

2 December 2017

publication date

1 March 2003

1 reference

Journal of Gastroenterology and Hepatology

2 December 2017

published in

1 reference

2 December 2017

volume

18

1 reference

2 December 2017

issue

3

1 reference

2 December 2017

page(s)

253-257

1 reference

The prevalence of hepatitis C virus infection in the United States, 1988 through 1994

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2003.02930.X

Clinical outcomes after transfusion-associated hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2003.02930.X

Mortality from liver cancer and liver disease in haemophilic men and boys in UK given blood products contaminated with hepatitis C. UK Haemophilia Centre Directors' Organisation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2003.02930.X

Liver biopsy in hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2003.02930.X

Measurement of serum hyaluronic acid in patients with chronic hepatitis C and its relationship to liver histology. Consensus Interferon Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2003.02930.X

Serum hyaluronan as a marker of liver fibrosis in chronic viral hepatitis C: effect of alpha-interferon therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2003.02930.X

An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2003.02930.X

Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2003.02930.X

Serum laminin and hyaluronan in liver cirrhosis: markers of progression with high prognostic value

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2003.02930.X

Serum hyaluronate reflects hepatic sinusoidal capillarization

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2003.02930.X

Histopathology of chronic hepatitis C in relation to epidemiological factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2003.02930.X

Prognostic value of serum hyaluronan in patients with compensated HCV cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2003.02930.X

10.1046/J.1440-1746.2003.02930.X

21 January 2018

Identifiers

DOI

1 reference

2 December 2017

1 reference